Stem Cell Treatment Color Blindness

Learn about the symptoms causes diagnosis and treatment of stargardt disease and current research.

Stem cell treatment color blindness.

The stem cell derived ocular cells were developed in part by researchers at uc santa barbara. Stem cell therapy 2 324 stem cell tourism 199 stem cells 523 veterinary medicine 507. This study represents real progress in regenerative medicine and opens the door on new treatment options for people with amd said coffey we hope this will soon lead to an affordable off the shelf therapy. And maureen neitz ph d who are both professors of ophthalmology at the university of washington have already had success treating color blindness in monkeys using gene therapy.

Unfortunately there arent many color blindness tests available online. Researchers are now using stem cell technology to explore possible new approaches to treatments for loss of vision. Loss of vision can have a huge impact on a person s life but many of the disorders that cause blindness are currently difficult or impossible to treat. 0 0 0 0.

This means there is definitely one in your neighborhood or school class affected by it. Go back to previous page back to news new research reveals stem cell therapy could cure certain types of blindness 18 07 2018 within as little as five years one of the most common causes of blindness could be cured and available to the public. So this page shall bring together a series of tests to check your personal type of color vision deficiency and the severity of it. Stargardt disease is an inherited disorder that usually causes vision loss in childhood or adolescence.

Age related macular degeneration amd is the third leading cause of blindness worldwide with almost 1 75 million people in the us this equates to 2 4. Blindness caused by disorders such as retinitis pigmentosa and macular degeneration are considered to be good candidates for stem cell therapies. Stem cell treatment color blindness. Stem cell treatments for eye disease always seem to be just on the horizon but real progress is being made.

Injecting treatment in to a blind eye carries low risks as eyes are encapsulated and wayward cells likely would not travel to other parts of the body. Color blindness affects approximately every 1 in 12 men 8 and 1 in 200 women 0 5. It is also called stargardt macular dystrophy juvenile macular degeneration or fundus flavimaculatus. A one shot treatment for color blindness may begin human trials as soon as 2017 if current testing goes well.

A new treatment for macular degeneration is close to the next stage of human testing a noteworthy event not just for the millions of patients it could help but for its potential to become the first therapy based on embryonic stem cells.